Please login to the form below
vaccine trials
This page shows the latest vaccine trials news and features for those working in and with pharma, biotech and healthcare.
Results for GSK’s RSV vaccine candidate published in New England Journal of Medicine
coordinator of the vaccine clinical trials unit at the Instituto de Investigación Sanitaria de Santiago in Spain. ... 1%. Positive vaccine efficacy was also observed in participants with comorbidities of interest, underlining the potential impact of the
Latest news
-
GSK and CureVac to advance mRNA COVID-19 and flu vaccine candidates
The vaccines produced promising preliminary results in phase 1 trials. GSK and CureVac will be advancing their jointly developed mRNA COVID-19 and flu vaccine candidates to the next stage of ... While the COVID-19 programme tested two monovalent
-
Novavax’s COVID-19 vaccine receives MHRA approval for use as a booster
vaccine. In the Novavax-sponsored trials, following the booster, local and systemic reactions were generally short-lived with a median duration of approximately two days, the company reported. ... Currently available clinical and preclinical data
-
New study identifies gene associated with strong immune response to COVID-19 vaccines
The researchers initially analysed DNA samples from 1, 190 participants who enrolled at the University of Oxford’s COVID-19 vaccine clinical trials, as well as from 1, 677 adults who ... They also looked at DNA samples from children who had
-
Novavax’s COVID-19 vaccine candidate approved by MHRA for adolescents aged 12 to 17
Preliminary safety data from the paediatric expansion showed the vaccine to be generally well-tolerated. ... In both trials, the vaccine demonstrated efficacy with a reassuring safety profile.
-
Moderna’s Omicron booster receives MHRA approval
Moderna’s COVID-19 booster vaccine has been approved by the Medicines and Healthcare products Regulatory Agency (MHRA). ... He added: “mRNA- 1273.214 has consistently shown superior breadth of immune response over mRNA-1273 in clinical trials.
More from news
Approximately 1 fully matching, plus 140 partially matching documents found.
Latest Intelligence
-
Expanding clinical trial access: a global imperative requiring local focus
In our most recent work in COVID-19 vaccine and treatment trials, there were several key ways that intentional a priori design and execution helped broaden participation among underserved populations that ... key. In our work on US-based COVID-19 vaccine
-
Fair representation in research matters to the sector and to society
In the US, both Pfizer and Moderna worked with community organisations to increase representation in the COVID-19 vaccine trials. ... Community organisations can play a critical role improving representation in health research and trials.
-
How will COVID-19 affect uptake of vaccinations against other diseases?
Not just for the COVID-19 programmes, but for every other vaccine made these days. ... no large-scale clinical trials having been completed, caused widespread concern among the scientific community.
-
Multilingual remote conferencing and interpreting platforms in the era of COVID-19
In April this year there were 650 groups around the world carrying out 460 different coronavirus vaccine trials on hundreds of thousands of individuals from different nationalities. ... will lead to even greater engagement with medical and clinical
-
Developing a COVID-19 vaccine
Pharma giant Johnson &Johnson is also at the forefront of developing a COVID-19 vaccine, having said it plans to start clinical trials of its lead candidate in September. ... Researchers from Oxford University have also said they plan to start clinical
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest appointments
-
Andrew Gengos joins ImmunoCellular as CEO
Will lead company as it initiates phase II trials investigating brain tumour vaccine. ... Gengos joins at an important time for ImmunoCellular, with the company having recently commenced a phase II trial investigating its lead product candidate ICT-107,
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Diversity in Clinical Trials: A more inclusive approach in patient recruitment
We have seen a growing focus on patient diversity in clinical trials in recent years, but the COVID-19 vaccine trials in particular have highlighted the importance of achieving diverse patient ... Speakers. Kate Shaw - Founder/CEO - Innovative Trials.
-
What does the future hold for clinical trial recruitment?
This work is ongoing as the virus mutates; last month, it was announced that Pfizer and BioNTech had started clinical trials for a new Covid vaccine targeting the Omicron variant. ... While Covid-19 vaccine trials have garnered headlines these have
-
How to innovate and influence people in times of misinformation
but that thanks to new mRNA technology, vaccine prototypes would be ready for trials within weeks and the first shots would go into arms before the end of 2020, what would
-
#DemandDiversity: We’re calling on the clinical trials industry to include us all
The lack of diversity in clinical trials is something we’ve spoken about time and time again. ... Here are the statistics we shared:. Of the 270, 000 people signed up to the NHS vaccine registry for COVID-19 clinical trials:.
-
The unheard, unseen, and uncorrected effects of COVID-19
groups, and to understand whether this hindered people’s willingness to participate in COVID-19 vaccine clinical trials. ... This can be seen by the lack of willingness of Black participants to take part in COVID-19 vaccine trials — 94.3% of surveyed
More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.
Subscribe to our email news alerts
- Senior Medical Copywriter - Highly Awarded Advertising Agency
- £50,000 - £60,000 yearly
- Market Access Director, six figure base salary and £5K joining b...
- Highly competitive salary
- Home Based Account Manager, Medical Communications, UK, Pharma/M...
- Highly competitive salary
- Account Director, Healthcare Marketing Creative Agency, Fixed te...
- Highly competitive salary
- Account Manager, Healthcare Marketing Creative Agency, Fixed ter...
- Highly competitive salary
- Account Manager, 6 month contract, Healthcare Brand communicatio...
- Highly competitive salary
- AbbVie’s Rinvoq receives FDA approval for Crohn’s disease
- Bayer’s Nubeqa combination recommended by NICE to treat metastatic prostate cancer
- AstraZeneca announces positive phase 3 results for Tagrisso combination in lung cancer
- Novo Nordisk announces positive phase 3 results for oral weight-loss drug
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- FDA approves Blueprint Medicines’ Ayvakit for indolent systemic mastocytosis
- Medscape Medical Affairs Selected as Finalist for 2023 Communiqué Awards
- COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
- BMS and Janssen’s antithrombotic granted FDA fast track designation
- Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- Shining a Spotlight on Women’s Health Education Outcomes at ACOG 2023
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- Patient Clinical Trial & Communications Plan Review: A Customer Story
- ...
- Working together to achieve better patient pathways
- Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
- Design-thinking. Iterating for continuous improvement.
- How design can lead improvement within Pharma...
